rs141449330

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PP3BP6_Very_StrongBS1BS2

The NM_031844.3(HNRNPU):​c.875C>T​(p.Thr292Ile) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000402 in 1,566,688 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000040 ( 0 hom. )

Consequence

HNRNPU
NM_031844.3 missense, splice_region

Scores

4
11
4
Splicing: ADA: 0.9975
2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 8.05

Publications

0 publications found
Variant links:
Genes affected
HNRNPU (HGNC:5048): (heterogeneous nuclear ribonucleoprotein U) This gene encodes a member of a family of proteins that bind nucleic acids and function in the formation of ribonucleoprotein complexes in the nucleus with heterogeneous nuclear RNA (hnRNA). The encoded protein has affinity for both RNA and DNA, and binds scaffold-attached region (SAR) DNA. Mutations in this gene have been associated with epileptic encephalopathy, early infantile, 54. A pseudogene of this gene has been identified on chromosome 14. [provided by RefSeq, Jun 2017]
HNRNPU Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 54
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PP3
Splicing predictors support a deleterious effect. Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
BP6
Variant 1-244862463-G-A is Benign according to our data. Variant chr1-244862463-G-A is described in ClinVar as Likely_benign. ClinVar VariationId is 406727.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0000405 (6/148290) while in subpopulation SAS AF = 0.00043 (2/4652). AF 95% confidence interval is 0.0000754. There are 0 homozygotes in GnomAd4. There are 3 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 6 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNRNPUNM_031844.3 linkc.875C>T p.Thr292Ile missense_variant, splice_region_variant Exon 3 of 14 ENST00000640218.2 NP_114032.2 Q00839-1Q96BA7
HNRNPUNM_004501.3 linkc.818C>T p.Thr273Ile missense_variant, splice_region_variant Exon 3 of 14 NP_004492.2 Q00839-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNRNPUENST00000640218.2 linkc.875C>T p.Thr292Ile missense_variant, splice_region_variant Exon 3 of 14 1 NM_031844.3 ENSP00000491215.1 Q00839-1

Frequencies

GnomAD3 genomes
AF:
0.0000405
AC:
6
AN:
148250
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000428
Gnomad FIN
AF:
0.000106
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000444
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000600
AC:
15
AN:
250150
AF XY:
0.0000961
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000353
Gnomad OTH exome
AF:
0.000164
GnomAD4 exome
AF:
0.0000402
AC:
57
AN:
1418398
Hom.:
0
Cov.:
30
AF XY:
0.0000481
AC XY:
34
AN XY:
707488
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32486
American (AMR)
AF:
0.0000226
AC:
1
AN:
44188
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25544
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39108
South Asian (SAS)
AF:
0.000329
AC:
28
AN:
85046
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52846
Middle Eastern (MID)
AF:
0.000356
AC:
2
AN:
5616
European-Non Finnish (NFE)
AF:
0.0000214
AC:
23
AN:
1074864
Other (OTH)
AF:
0.0000511
AC:
3
AN:
58700
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000405
AC:
6
AN:
148290
Hom.:
0
Cov.:
32
AF XY:
0.0000417
AC XY:
3
AN XY:
72026
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
40150
American (AMR)
AF:
0.00
AC:
0
AN:
14862
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3444
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4984
South Asian (SAS)
AF:
0.000430
AC:
2
AN:
4652
European-Finnish (FIN)
AF:
0.000106
AC:
1
AN:
9396
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
278
European-Non Finnish (NFE)
AF:
0.0000444
AC:
3
AN:
67576
Other (OTH)
AF:
0.00
AC:
0
AN:
2042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000283
Hom.:
0
Bravo
AF:
0.0000264
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000576
AC:
7
EpiCase
AF:
0.0000547
EpiControl
AF:
0.00

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 54 Benign:1
Sep 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Mar 06, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

HNRNPU-related disorder Benign:1
Feb 11, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.61
BayesDel_addAF
Benign
-0.0044
T
BayesDel_noAF
Uncertain
0.060
CADD
Pathogenic
34
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.49
.;T;T;.
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.74
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.97
D;D;D;D
M_CAP
Benign
0.049
D
MetaRNN
Uncertain
0.48
T;T;T;T
MetaSVM
Uncertain
-0.047
T
MutationAssessor
Benign
2.0
.;M;.;.
PhyloP100
8.1
PrimateAI
Pathogenic
0.81
D
PROVEAN
Uncertain
-3.8
D;.;D;.
REVEL
Uncertain
0.62
Sift
Uncertain
0.0030
D;.;D;.
Sift4G
Uncertain
0.0070
D;.;.;.
Polyphen
0.99
D;D;.;.
Vest4
0.82
MVP
0.70
ClinPred
0.59
D
GERP RS
5.4
PromoterAI
-0.043
Neutral
RBP_binding_hub_radar
0.97
RBP_regulation_power_radar
2.7
Varity_R
0.50
gMVP
0.63
Mutation Taster
=75/25
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
0.81
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141449330; hg19: chr1-245025765; API